Year |
Citation |
Score |
2024 |
Chen C, Chen C, Cao L, Fang J, Xiao J. Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study. International Immunopharmacology. 133: 112022. PMID 38615382 DOI: 10.1016/j.intimp.2024.112022 |
0.355 |
|
2024 |
Chen C, Xie J, Gang J, Wang M, Wu K, Jiang A. Metabolomic insights into the browning inhibition of fresh-cut apple by hydrogen sulfide. Food Chemistry. 447: 139005. PMID 38507948 DOI: 10.1016/j.foodchem.2024.139005 |
0.325 |
|
2024 |
Coll JA, Dhar V, Chen CY, Crystal YO, Guelmann M, Marghalani AA, AlShamali S, Xu Z, Glickman GN, Wedeward R. Use of Vital Pulp Therapies in Primary Teeth 2024. Pediatric Dentistry. 46: 13-26. PMID 38449041 |
0.307 |
|
2023 |
Coll JA, Dhar V, Chen CY, Crystal YO, Guelmann M, Marghalani AA, AlShamali S, Xu Z, Glickman G, Wedeward R. Primary Tooth Vital Pulp Treatment Interventions: Systematic Review and Meta-Analyses. Pediatric Dentistry. 45: 474-546. PMID 38129755 |
0.308 |
|
2023 |
Bin Y, Tian M, Xie J, Wang M, Chen C, Jiang A. Bamboo leaf extract treatment alleviates the surface browning of fresh-cut apple by regulating membrane lipid metabolism and antioxidant properties. Journal of the Science of Food and Agriculture. PMID 38018275 DOI: 10.1002/jsfa.13181 |
0.318 |
|
2022 |
Chen C, Fu F, Ding L, Fang J, Xiao J. Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system. Frontiers in Immunology. 13: 938322. PMID 36172346 DOI: 10.3389/fimmu.2022.938322 |
0.352 |
|
2022 |
Li S, Chen C, Yang GL, Fang J, Sun Y, Tang L, Wang H, Xiang W, Zhang H, Croteau PL, Jayne JT, Liao H, Ge X, Favez O, Zhang Y. Sources and processes of organic aerosol in non-refractory PM and PM during foggy and haze episodes in an urban environment of the Yangtze River Delta, China. Environmental Research. 212: 113557. PMID 35640706 DOI: 10.1016/j.envres.2022.113557 |
0.344 |
|
2022 |
Ding L, Chen C, Yang Y, Fang J, Cao L, Liu Y. Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System. Cardiovascular Therapeutics. 2022: 9866486. PMID 35140810 DOI: 10.1155/2022/9866486 |
0.339 |
|
Show low-probability matches. |